Bacterial plasminogen activators are commonplace among microbial pathogens, implying a central role of host plasmin in supporting bacterial virulence. Group A streptococci (GAS) secrete streptokinase (SK), a specific activator of human plasminogen (PLG). The critical contribution of the SK-PLG interaction to GAS pathogenicity was recently demonstrated using mice expressing human PLG. To examine the importance of thrombin generation in antimicrobial host defense, we challenged mice with deficiency of FV in either the plasma or platelet compartment. Reduction of FV in either pool resulted in markedly increased mortality following GAS infection, with comparison to heterozygous F5-deficient mice suggesting a previously unappreciated role for the platelet FV pool in host defense. Mice with complete deficiency of fibrinogen also demonstrated markedly increased mortality to GAS infection relative to controls. Though FV Leiden may be protective in the setting of severe sepsis in humans, no significant survival advantage was observed in GAS-infected mice carrying the FV Leiden mutation. Taken together, our data support the hypothesis that local thrombosis/fibrin deposition limits the survival and dissemination of at least a subset of microbial pathogens and suggest that common variation in hemostatic factors among humans could affect host susceptibility to a variety of infectious diseases.
INTRODUCTION
Streptococcus pyogenes (Group A Streptococci or GAS) is estimated to result in over 700 million symptomatic human infections worldwide each year 1 , such as very common but mild pharyngeal and skin infections, as well as less frequent but life threatening diseases, such as toxic-shock-like syndrome and necrotizing fasciitis 2;3 . GAS is highly specific to its human host, whereas closely related bacterial species cause similar disorders in other mammals, including, strangles, a common pharyngeal infection in horses 4 .
All pathogenic GAS isolates express streptokinase (SK, encoded by the ska gene), a bacterial activator of plasminogen (PLG), the central enzyme in the host fibrinolytic system [5] [6] [7] [8] . SK forms a stoichiometric complex with PLG, inducing a conformational change in the PLG activation pocket and nonproteolytically converting PLG into an active serine protease. This complex subsequently proteolytically activates additional PLG molecules 9 . The SK from GAS is a highly specific activator of human PLG, whereas the SK generated by related bacterial species infecting other mammals can generally only activate plasminogen from the corresponding host 5;7;8 . We previously reported the generation of transgenic mice (hPLG) that express human plasminogen under the control of the murine albumin gene promoter. Though wild-type mice are highly resistant to infection with human pathogenic GAS strains, hPLG transgenic mice demonstrate markedly enhanced susceptibility and increased mortality. This dramatic difference in susceptibility is lost when the SK gene is removed to generate an SK − GAS strain, demonstrating that the SK/PLG interaction is critical for GAS pathogenicity in the mouse, and that SK is a key virulence factor 10 .
A number of other pathogens are known to produce host PLG activators, including staphylokinase from Staphylococcus aureus and the Pla protease from Yersinia pestis 11;12 .
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PLG activation may support GAS virulence by removing fibrin matrices surrounding local sites of infection and thereby facilitate microbial dissemination 10 , limiting fibrin-dependent leukocyte activation events leading to the local implementation of antimicrobial functions, or a combination of these mechanisms. To further explore these concepts, and further characterize the role of thrombin generation and PLG activation in GAS pathogenicity, we now report the analysis of GAS infection in mice with genetically engineered alterations in other hemostatic system components. Reduction in either the platelet or plasma FV pool markedly increases susceptibility to GAS, though the presence of FV Leiden fails to provide protection in this murine model. Fibrinogen deficiency also results in a dramatic increase in mortality following GAS infection, suggesting that the primary role of FV-dependent thrombin generation in this model is supporting the formation of the fibrin matrix.
MATERIALS AND METHODS

Bacterial growth and media
Streptococcal strains used for this study were derived from the GAS M type 1 strain MGAS166. UMAA2616 (previously designed as UMAA2392) contains a site-directed deletion in the covR gene and a spontaneous mutation in the covS gene as previously reported 14 .
Streptococci were cultured in Todd-Hewitt broth (Difco, Detroit, MI) containing 0.2% yeast extract (THY) supplemented with streptomycin.
Genetically engineered mice
The generation of fibrinogen-deficient mice carrying an inactivating mutation of the fibrinogen α chain gene has been previously reported 15 . The Fga+/-and Fga-/-mice studied here were all derived from a backcross into C57BL/6J for > 6 generations (>N6). The generation of Fibγ 390-396A mice expressing a mutant form of fibrinogen that is unable to support α M β 2 -mediated adhesion of primary neutrophils, monocytes, and macrophages has been described previously 16 . The generation of transgenic mice (Tg+) with FV expression specifically restricted to either the plasma (AlbfvB, AlbfvC) or platelet (Pf4fvA) pools, were previously reported 17 . The latter animals were bred into the FV deficient (F5-/-) background in a two generation mating scheme to generated mice (Tg+F5-/-) with different expression levels of FV in the plasma and platelet pools, as previously described 17 . To improve the yield of Tg+F5-/-mice available for study, Tg+F5+/-mice in the C57Bl/6J background (>N6) were crossed to SJL/J mice and the Tg+F5+/-F1 offspring backcrossed to C57BL/6J F5+/-mice to generate Tg+F5-/-animals.
Transgenic and nontransgenic F5+/-and F5+/+ littermates were used in all experiments to control for the effect of potential strain background differences.
The generation of transgenic mice with liver-specific expression of human PLG was previously described 10 . The mice used for the current study will be denoted as hPLG+, and correspond to the AlbPLG1 transgenic line reported in reference 10. Mice carrying the ortholog of human FV Leiden were previously generated by a "knockin" of the R504Q mutation into the endogenous murine F5 locus by homologous recombination 18 . This allele is designated here as 
GAS infection model
Mice were injected subcutaneously with GAS as previously described 10 . Briefly, an overnight culture from a single GAS colony was diluted 1:10 into fresh THY medium and grown to late log phase (OD 600nM =0.75). Six to eight week old mice were injected into the right flank with 100 µl of culture diluted to the desired colony number in THY medium, with serial dilutions of the same bacterial cultures plated on THY plates to determine the exact inoculation titer.
Mice were monitored for nine days for mortality.
A cohort of Fga+/-and Fga-/-mice inoculated with 2X10 6 CFU GAS was studied for dissemination to the spleen as described previously 10 . At 64 hours post-inoculation, mice were sacrificed, spleens were dissected and homogenized in 5ml THY broth and cultured quantitatively on THY-streptomycin plates to estimate the CFU. 
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RESULTS
Decreased FV level increases host susceptibility to GAS infection
We previously demonstrated that the SK/PLG interaction plays a critical role in GAS pathogenicity, and hypothesized that SK functions to hijack the host fibrinolytic system to remove the fibrin matrices surrounding sites of infection and thus facilitate bacterial growth and dissemination 10 . To characterize the role of thrombin generation in host defense against GAS, we took advantage of a series of genetically engineered mouse lines with altered levels and tissue specific distributions of FV, a critical component of the prothrombinase complex. We previously generated transgenic mice with decreased levels of FV restricted to either the plasma or platelet pools by crossing tissue specific transgenes into the F5 null background (Tg+F5-/-) 17 .
Three lines of mice (AlbfvB, AlbfvC and Pf4fvA) were used for the current experiments.
AlbfvBTg+F5-/-mice express approximately 15% of the wild-type plasma FV level, with no detectable platelet FV expression 17 . No significant difference in mortality following GAS infection was observed between F5+/+ and F5+/-mice, with or without a F5 transgene, across inoculation doses ranging from 3.6X10 6 to 2.6X10 8 CFU (colony forming unit) (p>0.6) ( Figure   1 ). For all subsequent experiments, all of these animals were considered together as a single control group designated F5+. All the F5+ mice (F5+/-or F5+/+, with or without a transgene)
were expected to have levels of F5 expression >50% of wild-type F5+/+ mice.
AlbfvBTg+F5-/-mice demonstrated markedly increased susceptibility to infection with GAS
strain UMAA2616 compared to their sibling controls across a wide range of inoculation doses
mortality by day 5, compared to 6% mortality in control F5+ mice (Figure 2A) . At a ~ 100-fold higher GAS dose (2.6X10 8 CFU), mortality for Tg+F5-/-was 100% by day 2, compared to 40%
in control mice (p < 0.004, Figure 1C ). Pooling the survival data across all inoculation doses ( Figure 1D ), Tg+F5-/-mice demonstrated 83% mortality compared to 11% in controls (p<6X10 -15 ).
Thus, FV expression reduced to 15% of wild-type (F5+/+) and restricted to the plasma pool (AlbfvBTg+F5-/-mice) results in markedly increased mortality following GAS infection. To distinguish the effects of reduced plasma FV from the absence of platelet FV, a similar series of experiments were conducted in AlbfvCTg+F5-/-transgenic mice, which also exhibit absent platelet FV but with approximately 45% of the plasma FV level observed in wild-type mice (compared to 15% in AlbfvBTg+F5-/-mice). As shown in Figure 3A , AlbfvCTg+F5-/-mice also exhibited increased mortality by day 9 (24% compared to 3% in littermate controls, p<0.03, 4.0X10 6 CFU). Higher mortalities were observed at higher doses of infection (50% at 3.6X10 7 CFU and 100% at 2.6X10 8 CFU, Figure 3B -C). Combining data across all doses tested, AlbfvCTg+F5-/-mice exhibited significantly increased mortality by day 9 (40% compared to 12% in littermate controls, p<0.002, Figure 3D ).
A comparison between the pooled survival data for the two plasma-specific FV transgenic lines is shown in Figured 3E . Significantly greater mortality was observed with the lower plasma FV levels of AlbfvBTg+F5-/-mice (83% mortality by day 9, compared to 40% in AlbfvCTg+F5-/-, p<0.0009). Thus, even a modest reduction in plasma FV from 45% to 15%
(levels that would not be expected to result in significant clinical bleeding 17;19 ), was associated with markedly increased mortality following GAS infection. These results demonstrate a critical dependence of host defense against GAS on the quantitative capacity for thrombin generation in plasma. Prothrombin Times (PT) in platelet poor plasma samples were also significantly longer in AlbfvBTg+F5-/-(20.9±5.13 seconds) than in F5+/-(10.55±0.33 seconds) (p<0.013, n=3 for each group of mice).
The increased mortality observed in AlbfvCTg+F5-/-mice ( Figure 3A -D) could result either from the modest reduction in plasma FV (to ~45% of wild-type), the absence of FV from the platelet pool, or a combination of these effects. As shown in Figure 1 , F5+/-mice with similar plasma FV levels (50% compared to 45% in AlbfvCTg+F5-/-mice), but 50% platelet F5 levels (compared to <1% in AlbfvCTg+F5-/-mice), were resistant to GAS-associated mortality and indistinguishable from wild-type F5+/+ mice. These data suggest that the enhanced mortality observed in AlbfvCTg+F5-/-is due primarily to the absence of the platelet FV pool and imply a critical role for platelet FV in host defense from GAS, and potentially other microbial pathogens.
To further examine the role of platelet factor V mice engineered to restrict FV only to the platelet pool (Pf4fvATg+F5-/-) 17 were also tested in this GAS infection model. As shown in Figure 3F , Pf4fvATg+F5-/-mice were also highly susceptible to UMAA2616 infection, with 83% mortality compared to 12% mortality in littermate controls (p<9X10 -5 ) ( Figure 3F ). Of note, Pf4fvATg+F5-/-mice express only approximately 3% of the wild-type platelet FV level. Thus, the increased mortality in these animals could be due either to the reduced level of platelet FV or the absence of the plasma FV pool (or a combination of both). However, taken together, these data suggest that both the plasma and platelet pools of FV are required for optimal host defense against GAS infection.
Decreasing fibrinogen level increases host susceptibility to GAS infection
The data presented above demonstrate a critical role for the prothrombinase complex, and the resulting generation of thrombin, in host defense against GAS. Though we hypothesize that the fibrin generated by thrombin action provides a critical barrier against GAS dissemination and fibrin-dependent implementation of leukocyte antimicrobial programs, thrombin has a myriad of other functions, which could also contribute to host defense, include platelet activation, activation of protein C, and initiation of cellular signaling pathways 20;21 . To separate the role of fibrin generation from other functions of thrombin, we next examined the consequences of GAS infection in mice with a genetic deficiency in plasma fibrinogen 15 .
Fga-/-and littermate Fga+/-mice were infected with GAS strain UMAA2616, with the resulting survival curves shown in Figure 4 . Fga-/-mice exhibited 80% mortality by day 4 compared to 20% mortality in heterozygote Fga+/-littermates (p<0.05) ( Figure 4A ). A similar survival difference was still observed at a 70-fold lower inoculation dose (p<0.03, Figure 4B ).
Though the difference did not reach significance, we also observed a trend toward increased GAS colony counts in the spleen of infected Fga-/-mice at day 2, compared to Fga+/-littermates (p=0.15) (Figure 5 ), consistent with increased systemic spread.
Analysis of GAS susceptibility in cohorts of Fga+/+ mice compared to Fga+/-mice carrying marginally lower (~20% decrease) 15 plasma fibrinogen levels revealed no significant difference (p>0.3) in survival ( Figure 6 ). Thus, complete absence of fibrinogen in Fga-/-mice results in marked increased mortality following GAS infection, whereas little of no effect is evident from an ~20% reduction in plasma fibrinogen (Fga+/-).
Fibrin(ogen) also supports leukocyte adhesion and activation events via the leukocyte integin α M β 2 , an interaction which is critical for bacterial clearance 22 . In order to distinguish between this property of fibrin(ogen) from all other functions in the GAS infection model, Fibγ
390-396A
mice expressing a mutant form of fibrinogen lacking the α M β 2 binding motif were tested for GAS susceptibility. Significant differences in survival were observed. While all tested Fga-/-mice succumbed to GAS infection by day 4, Fibγ 390-396A mice demonstrated a delayed mortality, with improved survival (p < 0.023, Figure 4C ).
FV Leiden does not reduce GAS-related mortality in the mouse
FV Leiden is the most common genetic predisposition to thrombosis, with prevalence of ~4-6% in European populations 23 . FV carrying the R506Q Leiden mutation is resistant to inactivation by APC cleavage, leading to increased thrombin generation, presumably accounting for the associated elevated risk of venous thrombosis in Factor V Leiden carriers 24;25 . FV Leiden has been reported to protect against endotoxin challenge in mice and to confer a survival advantage for human patients with severe sepsis 26 .
In light of the enhanced susceptibility of FV-deficient mice to GAS infection, we next tested whether the FV Leiden gain-of-function mutation would afford protection in this model system.
We previously generated a mouse model of FV Leiden by a "knockin" of the orthologous F5 R504Q substitution into the mouse F5 gene 18 . Similar to humans, mice carrying the murine FV Leiden mutation are mildly prothrombotic, though otherwise phenotypically normal.
A genetic cross between hPLG transgenic mice 10 and factor V Leiden mice 18 was performed to generate GAS susceptible mice carrying hPLG either in the presence (hPLG+F5Q/+) or absence (hPLG+F5+/+) of the FV Leiden allele (F5Q/+). Consistent with our previous report 10 , mice carrying the hPLG transgene (hPLG+) demonstrated markedly increased mortality following GAS infection (p<6X10 -9 ) (Figure 7 ) 10 . However, no significant difference in mortality is observed as a function of FV Leiden allele status, either in the presence (hPLG+) (p>0.5) or absence (hPLG-) (p>0.2) of the hPLG transgene ( Figure 7) . Thus, at least in this GAS subcutaneous infection model, FV Leiden does not confer protection from mortality.
Discussion
We previously reported markedly increased mortality following GAS infection in mice genetically engineered to carry human PLG, and showed that this increased susceptibility was dependent on the species-specific interaction of SK with PLG 10 . Our data further suggested that local fibrin formation was critical to the host defense against microbial spread and that SK served to co-opt the host fibrinolytic system to overcome fibrin-related immune surveillance mechanisms and barrier function. The current study confirms and extends these findings and demonstrates the critical role of thrombin generation in the host defense against GAS. Our findings identify important contributions from both the platelet and plasma FV pools to this process and suggest that the primary function of thrombin in this setting is focused on the generation of the fibrin matrix.
Factor V is a central regulatory protein in the blood coagulation cascade, together with Factor X forming the prothrombinase complex, which cleaves prothrombin into active thrombin. Factor X maintains little or no prothrombin activity in the absence of FV and mice completely deficient in FV exhibit a mixed embryonic and perinatal lethal phenotype 27 that is indistinguishable from prothrombin deficiency 28;29 .
In previous studies, we demonstrated that either platelet or plasma FV was sufficient for basal hemostasis, with no spontaneous hemorrhage observed in mice expressing 15-45% FV activity restricted to the plasma pool or mice with FV restricted to only the platelet pool (at ~3% of the wild-type level) 17 . In the current report we documented markedly increased mortalities following GAS infection in the same 3 groups of Tg+F5-/-mice compared to wild-type controls. AlbfvBTg+F5-/-mice compared to F5+/-mice. Taking together, these observations suggest that efficient thrombin generation via the prothrombinase complex is critical for effective host defense against GAS and potentially other pathogens.
The markedly enhanced susceptibility to GAS-induced mortality of mice with a 15% plasma FV level (AlbfvBTg+F5-/-), even in the absence of human plasminogen, suggests that this host defense pathway is considerably more sensitive to small changes in thrombin generation capacity than the general hemostatic pathways necessary for the maintenance of vascular integrity.
Though not statistically significant, a trend toward slightly increased mortality is observed in Figure 1 for F5+/-mice compared to F5+/+, suggesting that even a subtle ~50% reduction in FV (within the range of variation observed in the normal human and mouse populations) could be sufficient to impair host response to some pathogens 32 . The lower reserve in animals with reduced plasma FV levels could render the host particularly sensitive to further reductions in thrombin generation capacity resulting from the consumptive coagulopathy accompanying many bacterial infections.
Of particular note, the observation that AlbfvCTg+F5-/-mice are significantly more susceptible to GAS than F5+/-mice, despite similar levels of plasma FV (~45% vs. ~50%) suggests a key role for the platelet pool of FV in host defense from microbial pathogens.
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Platelet FV expresses greater prothrombinase cofactor activity and is also more resistant to APC 33 . These unique properties of platelet FV could account for our data and together suggest a unique role for the platelet FV pool in host defense against GAS infection. Platelets express adhesive and immune receptors on the surface to help recruitment of leukocytes, in addition to aggregating after contacting bacteria to form thrombi. Platelets also release antibacterial proteins from α -granules 34 . Our data provide an additional, potential novel mechanism for the function of the platelet in both innate and adaptive immunity 35 .
The current data demonstrating the critical role of thrombin generation in host defense against GAS is consistent with a model in which local fibrin deposition is critical to GAS containment and clearance. This model also explains the function of bacterial SK as a key virulence factor in GAS pathogenicity, with the resulting activation of host plasminogen resulting in breakdown of immobilizing fibrin matrices 10 . To more directly examine the role of fibrinogen/fibrin in this process, we took advantage of mice genetically engineered to be deficient in fibrinogen as the result of a knock out of the fibrinogen Aα chain gene 15 . Markedly increased susceptibility to GAS was observed in homozygous Fga-/-mice across a range of inoculation doses. These results are consistent with our previous observation that reduction of fibrinogen levels by injection of the snake venom ancrod similarly enhances GAS-related mortality 10 . Though SK binding to fibrinogen has previously been suggested as a necessary step at the first stage of bacterial invasion 13;36 , our data indicate that fibrinogen is not an absolute requirement for the initiation of GAS infection and suggest that the dominant action of fibrinogen in host defense is at the level of barrier function, limiting both microbial dissemination and supporting local inflammatory clearance mechanisms. Thrombin has a
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However, fibrinogen is a multi-functional protein that also plays critical roles in the inflammatory response. Fibrin(ogen) facilitates leukocyte activation events via interaction with the leukocyte integrin receptor α mice compared to Fga+/-controls suggests a similar role for fibrin(ogen) leukocyte interactions in the setting of GAS infection. However, the even greater and earlier mortality in Fga-/-mice ( Figure 4C ) demonstrates an important role for other functions independent of leukocytes. We hypothesize that the latter protective effect is largely due to a barrier function limiting vascular invasion and hematogenous spread.
The marked increase in susceptibility to GAS resulting from partial FV deficiency in our mouse model suggested that the gain of FV function associated with the common FV Leiden polymorphism could confer relative protection against this pathogen. Such protection would provide a balancing positive genetic selection that could potentially explain the high prevalence of FV Leiden in European populations 23 , despite the 4-10 fold elevated risk of venous thrombosis in Factor V Leiden carriers 24;25 . Though the data shown in Figure 7 suggest that FV Leiden does not protect against GAS infection, at least in this mouse subcutaneous model, we cannot exclude such a protective effect in humans or even other animal models of infection.
However, given the ubiquitous nature of GAS infection in human populations (estimated at >700 million cases per year) 1 , a polymorphism conferring significant resistance to GAS might be expected to be become rapidly fixed during human evolution, making GAS a less attractive candidate as a balancing selection for FV Leiden. Nonetheless, it seems likely that FV Leiden could provide an advantage in the setting of infection with another specific and less common bacterial pathogen, potentially through a similar hemostasis-dependent host response mechanism. Thus, the high prevalence of FV Leiden could be the result of an infection-related advantage, similar to the balancing selection thought to result from relative resistance to P.
faliciparum malaria in carriers of sickle cell anemia and thalassemia 38 . Consistent with this hypothesis, FV Leiden has been reported to confer a survival advantage among patients with severe sepsis 26 .
A large number of invasive bacterial species are known to generate proteins that interact with host coagulation factors [39] [40] [41] [42] , especially host plasminogen and fibrinogen. It seems likely that many of these organisms have adapted a similar strategy to that of GAS to circumvent this ancient vertebrate host defense system. A continuing "arms race" between microbes and their hosts could provide an evolutionary driving force for maintaining genetic variation within the genes for a number of hemostatic factors. Our data suggest that genetic variation in the plasma levels of FV, fibrinogen and plasminogen could be particularly significant determinants of response among human patients to a variety of infectious agents. It is worth noting that fibrinogen levels show an approximately 3-fold variation among inbred mouse lines, very similar to the wide variation in plasma fibrinogen observed in human populations 43 . These results suggest the possibility that plasma fibrinogen level might be a particularly important host susceptibility factor for human microbial infection and may also explain the evolution of plasma fibrinogen level as an acute phase reactant. These data also suggest the possibility that pharmacologic manipulation of the hemostatic system may offer opportunities for the development of novel therapeutic approaches to the treatment of infection diseases. HS performed research, analyzed data and wrote the paper, XW performed research, JLD analyzed data, wrote the paper, DG designed research, analyzed data and wrote the paper. We thank Elizabeth A. Grunz for performing PT assay. There are no conflicts of interest to declare. 
